Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Case Studies
Case Studies: Myeloproliferative Neoplasms
Expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
SORT BY:
A-Z
Recent
VIEW AS:
Grid
List
Primary Myelofibrosis
A 58-Year-Old Woman with Polycythemia Vera
JAK Inhibition for the Management of Primary Myelofibrosis
Polycythemia Vera
The Clinical Management of Primary Myelofibrosis
Diagnosis and Treatment of Myelofibrosis
Managing Uncontrolled Polycythemia Vera
A Case of Hydroxyurea Intolerant Polycythemia Vera
High-Risk Primary Myelofibrosis
Hydroxyurea Resistant Polycythemia Vera
Underlying Treatment of Myeloproliferative Neoplasms
Uncontrolled Polycythemia Vera
Harry Erba, MD, PhD, provides information on the diagnosis and treatment of patients with polycythemia vera
Srdan Verstovsek, MD, provides information on the diagnosis and treatment of patients with polycythemia vera
JTT Articles
Participating Practices Commend CMS for OCM Changes
The Role of Liquid Biopsy in NSCLC Continues to Emerge
Rare Incidence of ICI-Related Hepatotoxicity Frequently Ends in Treatment Discontinuation
>> View Peer-Reviewed Articles
Most Popular
Diagnosing ALK+ NSCLC
Expert Discusses Challenges and Future Opportunities in Treating Myelofibrosis
Early Data From DREAMM-2 Trial Promising for Belantamab Mafodotin in Relapsed Multiple Myeloma
Expert Highlights Data that Led to the Approval of Fedratinib in Myelofibrosis
Publications
